Kompanie Healthcare Partners LLP

Women’s Health, OB/GYN & Reproductive Fertility MSO Architecture

Integrate clinical OB/GYN practices with high-margin IVF fertility centers and embryology laboratories, build recurring cash-pay cryostorage revenues, and command 13x–17x EBITDA multiples.

Women’s healthcare has become one of the premier destination sectors for healthcare private equity. The strategic combination of broad, insurance-reimbursed obstetrics and gynecology (OB/GYN) feeder networks with elite, out-of-pocket cash-pay Reproductive Endocrinology and In Vitro Fertilization (IVF) fertility clinics creates exceptional margins and defensive recurring revenues. IVF platforms benefit from recurring annual cryopreservation storage subscription fees, high-acuity embryology lab margins, and pre-implantation genetic testing (PGT). However, managing physician on-call burnout, delivery liability insurance, and donor egg regulatory compliance requires robust operational structuring. Kompanie LLP advises PE sponsors in designing premier women’s health MSOs.

Deliverables

  • Turnkey Friendly Women’s Health PC corporate charters and governance.
  • Comprehensive IVF and Embryology Laboratory Management Agreement.
  • Hospitalist Laborist Shift Compensation and On-Call Scheduling model.
  • Cryopreservation storage recurring billing agreement templates.

Execution phases

  • Stage 1: Clinical Portfolio & Cryostorage Audit — Audit IVF lab accreditations, cryostorage subscription contracts, global maternity billing distribution, and medical malpractice loss runs.
  • Stage 2: MSO Labor & On-Call Optimization — Establish dedicated laborist hospitalist shift programs to liberate clinical OB/GYNs from delivery burnout, expanding outpatient clinic capacity.
  • Stage 3: IVF Lab Expansion & Regional Consolidation — Funnel regional OB/GYN patient referrals into platform embryology labs, expand donor egg banks, and scale secondary MSO multiple.

Diligence red flags

  • Fertility clinic cryostorage tanks lacking continuous digital telemetry and backup power, exposing the platform to catastrophic tissue loss liability.
  • High OB/GYN partner burnout and turnover caused by unmanaged 24/7 delivery call schedules following private equity acquisition.
  • Commercial carriers clawing back unbundled global maternity care fees (CPT 59400) due to improper antepartum visit splits.
  • Lack of legal clarity surrounding donor embryo and third-party reproductive tissue ownership in acquisition agreements.

Frequently asked questions

Why do fertility (IVF) clinics command higher multiples than general OB/GYN practices?

Fertility clinics operate primarily on an upfront, out-of-pocket cash-pay basis ($15,000 to $25,000 per IVF cycle) with zero commercial insurance denial risk, paired with high-margin recurring annual cryostorage fees, driving valuations to 14x–17x EBITDA.

How does an MSO resolve the severe physician burnout associated with OB/GYN practices?

We implement specialized OB Hospitalist (Laborist) programs that handle hospital deliveries during nights and weekends, allowing outpatient clinic physicians to focus purely on high-margin gynecologic surgeries and fertility consults.